5-154053016-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000522782.6(MFAP3):c.392G>A(p.Arg131His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R131C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000522782.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFAP3 | NM_005927.5 | c.392G>A | p.Arg131His | missense_variant | 3/3 | ENST00000522782.6 | NP_005918.1 | |
MFAP3 | NM_001242336.2 | c.392G>A | p.Arg131His | missense_variant | 3/3 | NP_001229265.1 | ||
MFAP3 | NM_001135037.2 | c.-47G>A | 5_prime_UTR_variant | 2/2 | NP_001128509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFAP3 | ENST00000522782.6 | c.392G>A | p.Arg131His | missense_variant | 3/3 | 1 | NM_005927.5 | ENSP00000430852 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151868Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251182Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135760
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461612Hom.: 0 Cov.: 35 AF XY: 0.00000550 AC XY: 4AN XY: 727112
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151868Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74134
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at